Recent LYEL Stock Price | LYEL Stock Predictions | |
$2.20 | +184.09% |
$6.25 |
Recent LYEL Analyst Ratings Breakdown, Making LYEL Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 2 | 2 | 2 | 2 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 3 | 3 | 3 | 3 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 2.2 | 2.2 | 2.2 | 2.2 |
For the LYEL stock predictions from the analysts covering Lyell Immunopharma Inc, we have collected all of the individual LYEL stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering LYEL (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since LYEL stock predictions may vary widely, another useful metric to consider is the median LYEL stock prediction, which represents the price at which half of the analysts
made LYEL stock predictions that were higher and half made LYEL stock predictions that were lower. This makes for a different take on the LYEL stock predictions out there, as compared to average or mean.
And that median across all the individual LYEL stock predictions was: $6.0 as of 2024-04-26.
The very highest of the LYEL stock predictions for one year price target was $9.0, while the very lowest of the LYEL stock predictions in the analyst group was
$4.0 (with a standard deviation of $2.061). Get the latest Zacks research report on LYEL — FREE
Find out: LYEL next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
SSRM Stock Predictions
AVTR Stock Predictions
HMN Stock Predictions
XHR Stock Predictions
BAND Stock Predictions
MBT Stock Predictions
PCTI Stock Predictions
DOV Stock Predictions
DY Stock Predictions
|
|
Buy (2.80 out of 4) 23rd percentile
(ranked lower than approx. 77% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |